Sanegene Bio: Funding, Investors & Team (Oct 2026)
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. Its RNAi portfolio covers a broad range of therapeutic areas including cardiovascular and metabolic diseases, immunology-related diseases, and nervous system diseases
Sanegene Bio has raised $110M across 1 funding round on record, the most recent a Series B of $110M announced in Dec 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sanegene Bio Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Sanegene Bio Funding Rounds
Sanegene Bio Founders and Leadership Team
Contact details for the Sanegene Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Sanegene Bio Funding Compared to Other Biotechnology Startups
Sanegene Bio's latest round of $110M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sanegene Bio in Biotechnology and Woburn
Companies Similar to Sanegene Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Sanegene Bio Funding FAQs
What does Sanegene Bio do?
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. Its RNAi portfolio covers a broad range of therapeutic areas including cardiovascular and metabolic diseases, immunology-related diseases, and nervous system diseases
How much funding has Sanegene Bio raised?
Sanegene Bio has raised $110M across 1 round on record. The most recent is a Series B of $110M announced in Dec 2025.
When did Sanegene Bio last raise funding?
Sanegene Bio's most recent funding round on record is a Series B of $110M, announced in Dec 2025.
Who founded Sanegene Bio?
FundedIQ lists Weimin Wang (Founder) at Sanegene Bio.
Where is Sanegene Bio headquartered?
Sanegene Bio is based in Woburn, Massachusetts, United States.
How many employees does Sanegene Bio have?
Sanegene Bio is in the 51-100 employee band.
How does Sanegene Bio's funding compare to other Biotechnology startups?
Sanegene Bio's latest round of $110M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Sanegene Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sanegene Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.